M. Gulec Et Al. , "Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study," JOURNAL OF AFFECTIVE DISORDERS , vol.134, pp.257-265, 2011
Gulec, M. Et Al. 2011. Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study. JOURNAL OF AFFECTIVE DISORDERS , vol.134 , 257-265.
Gulec, M., Selvi, Y., Boysan, M., Aydin, A., Besiroglu, L., & Agargun, M. Y., (2011). Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study. JOURNAL OF AFFECTIVE DISORDERS , vol.134, 257-265.
Gulec, Mustafa Et Al. "Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study," JOURNAL OF AFFECTIVE DISORDERS , vol.134, 257-265, 2011
Gulec, Mustafa Et Al. "Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study." JOURNAL OF AFFECTIVE DISORDERS , vol.134, pp.257-265, 2011
Gulec, M. Et Al. (2011) . "Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study." JOURNAL OF AFFECTIVE DISORDERS , vol.134, pp.257-265.
@article{article, author={Mustafa Gulec Et Al. }, title={Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study}, journal={JOURNAL OF AFFECTIVE DISORDERS}, year=2011, pages={257-265} }